As of 2026-03-05, the EV/EBITDA ratio of Molecular Partners AG (MOLN.SW) is -1.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOLN.SW's latest enterprise value is 73.99 mil CHF. MOLN.SW's TTM EBITDA according to its financial statements is -55.37 mil CHF. Dividing these 2 quantities gives us the above MOLN.SW EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.1x - 7.8x | 5.4x |
| Forward P/E multiples | 4.2x - 8.2x | 6.2x |
| Fair Price | (3.76) - (8.70) | (5.99) |
| Upside | -198.0% - -326.7% | -256.1% |
| Date | EV/EBITDA |
| 2026-03-05 | -1.40 |
| 2026-03-04 | -1.34 |
| 2026-03-03 | -1.35 |
| 2026-03-02 | -1.41 |
| 2026-02-27 | -1.36 |
| 2026-02-26 | -1.31 |
| 2026-02-25 | -1.27 |
| 2026-02-24 | -1.38 |
| 2026-02-23 | -1.35 |
| 2026-02-20 | -1.24 |
| 2026-02-19 | -1.41 |
| 2026-02-18 | -1.18 |
| 2026-02-17 | -1.21 |
| 2026-02-16 | -1.18 |
| 2026-02-13 | -1.03 |
| 2026-02-12 | -1.12 |
| 2026-02-11 | -1.11 |
| 2026-02-10 | -1.13 |
| 2026-02-09 | -1.15 |
| 2026-02-06 | -1.17 |
| 2026-02-05 | -1.14 |
| 2026-02-04 | -1.10 |
| 2026-02-03 | -1.03 |
| 2026-02-02 | -1.13 |
| 2026-01-30 | -0.93 |
| 2026-01-29 | -0.89 |
| 2026-01-28 | -0.78 |
| 2026-01-27 | -0.76 |
| 2026-01-26 | -0.83 |
| 2026-01-23 | -0.84 |
| 2026-01-22 | -0.82 |
| 2026-01-21 | -0.82 |
| 2026-01-20 | -0.87 |
| 2026-01-19 | -0.79 |
| 2026-01-16 | -0.87 |
| 2026-01-15 | -0.91 |
| 2026-01-14 | -0.97 |
| 2026-01-13 | -0.92 |
| 2026-01-12 | -1.00 |
| 2026-01-09 | -0.94 |
| 2026-01-08 | -0.95 |
| 2026-01-07 | -1.02 |
| 2026-01-06 | -1.08 |
| 2026-01-05 | -1.01 |
| 2025-12-30 | -1.01 |
| 2025-12-29 | -1.07 |
| 2025-12-23 | -1.04 |
| 2025-12-22 | -1.11 |
| 2025-12-19 | -1.15 |
| 2025-12-18 | -0.99 |